Clinical trial
Effect of Parenteral Glutamine on Myocardial Injury and Inflammation Biomarkers in Patients Undergoing to Cardiac Surgery With and Without Cardiopulmonary Bypass
NCT06065566 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Parenteral Glutamine on Myocardial Injury and Inflammation Biomarkers in Patients Undergoing to Cardiac Surgery With and Without Cardiopulmonary Bypass
- Lead sponsor
- Instituto Mexicano del Seguro Social
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2020
- Completion date
- February 4, 2022
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insufficiency;cardiac